Back to AG ADAGE CAPITAL PARTNERS GP, L.L.C.

DRUGDRUG
7 quarters

Position history for AGADAGE CAPITAL PARTNERS GP, L.L.C.'s holdings in BRIGHT MINDS BIOSCIENCES INC

ADAGE CAPITAL PARTNERS GP, L.L.C. holds 335,000 shares of DRUG (BRIGHT MINDS BIOSCIENCES INC), worth $23.5M as of 2026-Q2. The position was decreased (-32.4% shares). DRUG represents 0.0% of ADAGE CAPITAL PARTNERS GP, L.L.C.'s portfolio.

Current Value

$23.5M

Current Shares

335,000

Total Value Change

+$18.7M

Total Shares Change

+202,500

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
335,000
-32.4%
$23.5M0.0%$70.20
0
2026-Q1
Increased
495,743
+25.3%
$36.2M0.1%$80.00
36
2025-Q4
Unchanged
395,743
0.0%
$30.9M0.0%$75.85
0
2025-Q3
Increased
395,743
+97.9%
$24M0.0%$57.45
46
2025-Q2
Unchanged
200,000
0.0%
$5.2M0.0%$23.27
0
2025-Q1
Increased
200,000
+50.9%
$7.2M0.0%$36.50
38
2024-Q4
New
132,500
-
$4.8M0.0%$36.86
37

Other major holders of DRUG: Janus Henderson Group Ltd., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used